期刊文献+

Hippo信号通路在乳腺癌中的调控机制及作用 被引量:5

The regulatory mechanisms and functional roles of the Hippo signaling pathway in breast cancer
下载PDF
导出
摘要 Hippo信号通路是调控器官大小和肿瘤发生发展的关键通路,近年来受到广泛的关注。TAZ/YAP作为哺乳动物中Hippo信号通路两个核心下游效应分子,通过Hippo信号通路依赖性和非依赖性的机制受到细胞内外信号的严密调控。除了参与正常乳腺组织发育,Hippo信号通路还在人乳腺癌细胞的增殖、分化、凋亡、迁移、侵袭、上皮-间质转化和干性维持等多个过程中起着关键性作用。本文总结了Hippo信号通路的调控机制和调节信号,阐述了Hippo信号通路异常在乳腺癌发生发展中的作用,并讨论了其在乳腺癌中作为治疗靶点的临床策略。 Hippo signaling pathway has attracted broad attention due to its essential roles in controlling organ size and tumorigenesis. TAZ/YAP, two core downstream molecules of the Hippo signaling pathway in mammals, are tightly regulated by a wide range of extracellular and intrinsic signals in both Hippo signaling pathway-dependent and-independent manners. Besides their roles in the development and function of normal mammary glands, TAZ/YAP display remarkable potency and relevance to multiple aspects of human breast carcinogenesis, including cellular proliferation, differentiation, apoptosis, migration, invasion, epithelial-mesenchymal transition and stemness. In this review, we summarize the regulators of TAZ/YAP, discuss the significant contribution of the Hippo signaling pathway to human breast cancers and highlight their potential therapeutic roles.
出处 《遗传》 CAS CSCD 北大核心 2017年第7期617-629,共13页 Hereditas(Beijing)
基金 国家重点基础研究发展规划(973计划)项目(编号:2015CB910401) 国家自然科学基金项目(编号:81430057 81572686)资助~~
关键词 TAZ/YAP Hippo信号通路 乳腺癌 TAZ/YAP Hippo signaling pathway breast cancer
  • 相关文献

参考文献2

二级参考文献66

  • 1Pan D. The hippo signaling pathway in development and cancer. Dev Cell 2010, 19: 491-505.
  • 2Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human can?cer. Nat Rev Cancer 2013, 13: 246-257.
  • 3Zhao B, Li L, Lei Q, Guan KL. The Hippo-YAP pathway in organ size con?trol and tumorigenesis: an updated version. Genes Deu 2010, 24: 862-874.
  • 4Yu FX, Guan KL. The Hippo pathway: regulators and regulations. Genes Deu 2013, 27: 355-371.
  • 5Lei QY, Zhang H, Zhao B, Zha ZY, Bai F, Pei XH, Zhao S, et al. TAZ pro?motes cell proliferation and epithelial-mesenchymal transition and is inhib?ited by the Hippo pathway. Mol Cell Bioi 2008, 28: 2426-2436.
  • 6Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, Xie J, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhib?ition and tissue growth control. Genes Deu 20P7, 21: 2747-2761.
  • 7Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, Gayyed MF, et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007, 130: 1120-1133.
  • 8Hao Y, Chun A, Cheung K, Rashidi B, Yang X. Tumor suppressor LATSI is a negative regulator of oncogene YAP. J Bioi Chem 2008, 283: 5496-5509.
  • 9Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. A coordinated phosphor?ylation by Lats and CKI regulates YAP stability through SCF (beta-TRCP). Genes Dev 2010, 24: 72-85.
  • 10Liu CY, Zha ZY, Zhou X, Zhang H, Huang W, Zhao D, Li T, et al. The Hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCFfbetaJ-TrCP E3 ligase. J Bioi Chern 2010,285: 37159-37169.

共引文献13

同被引文献15

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部